Posts in: ARCHIVE

ARCHIVE: eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM ESTMay 7, 2025
ARCHIVE: eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
press releaseinvestornutraceuticalsmedicinescienceARCHIVE
ARCHIVE: eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver healthMay 6, 2025
ARCHIVE: AI transforming biotechnology: From form with AlphaFold to function with exozymes
investorvideoscienceARCHIVE
ARCHIVE: AI transforming biotechnology: From form with AlphaFold to function with exozymesApril 28, 2025
Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper.
press releaseinvestorvideoscienceARCHIVEkorman
ARCHIVE: GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymesApril 21, 2025
GEN Biotechnology
sciencepublicationARCHIVE
ARCHIVE: GEN Biotechnology: Exozymes for Biomanufacturing: Toward Clarity and Precision in the Cell-Free Space (cover story)April 17, 2025
ARCHIVE: Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman
investorpress clippingsvideoscienceARCHIVEkorman
ARCHIVE: Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler KormanApril 15, 2025
BioClick - an enzyme engineering game-changer
press releaseinvestorscienceARCHIVEkorman
ARCHIVE: BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grantApril 10, 2025
ARCHIVE: World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer
investorpress clippingsARCHIVEperriman
ARCHIVE: World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial OfficerApril 3, 2025
ARCHIVE: Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025
investorARCHIVE
ARCHIVE: Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025April 3, 2025
ARCHIVE: eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
talentpress releaseinvestorvideoARCHIVEperriman
ARCHIVE: eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCOApril 2, 2025
Previous page
Page 1 of 6
Next page